Roche Holding Ltd. (VTX:ROG) has been assigned a CHF 205 target price by stock analysts at HSBC Holdings PLC in a note issued to investors on Tuesday. The brokerage presently has a “sell” rating on the healthcare company’s stock. HSBC Holdings PLC’s price target would indicate a potential downside of 16.94% from the stock’s current price.
A number of other brokerages have also issued reports on ROG. J P Morgan Chase & Co reissued a “buy” rating and issued a price objective on shares of Roche Holding in a report on Thursday, November 2nd. Goldman Sachs Group, Inc. (The) set a CHF 325 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, September 11th. Credit Suisse Group set a CHF 300 price objective on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, September 11th. Berenberg Bank set a CHF 260 price objective on shares of Roche Holding and gave the company a “neutral” rating in a report on Tuesday, October 24th. Finally, set a CHF 203 price objective on shares of Roche Holding and gave the company a “sell” rating in a report on Friday, October 20th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. Roche Holding has an average rating of “Hold” and an average target price of CHF 261.78.
Shares of Roche Holding (VTX:ROG) opened at CHF 246.80 on Tuesday. Roche Holding has a 1-year low of CHF 218.30 and a 1-year high of CHF 273.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.